Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124155212 | 12415521 | 2 | F | 201512 | 20160801 | 20160530 | 20160805 | PER | US-PFIZER INC-2016249995 | PFIZER | 69.00 | YR | F | Y | 70.31000 | KG | 20160805 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124155212 | 12415521 | 1 | PS | NEURONTIN | GABAPENTIN | 1 | Oral | 6 DF, DAILY (TWO OF THE NEURONTIN IN THE MORNING, TWO IN THE MIDDLE OF THE DAY,AND TWO AT NIGHT) | Y | 20235 | 6 | DF | |||||||
124155212 | 12415521 | 2 | SS | NEURONTIN | GABAPENTIN | 1 | Y | 20235 | |||||||||||
124155212 | 12415521 | 3 | SS | LYRICA | PREGABALIN | 1 | Oral | 25MG, CAPSULES, BY MOUTH, THREE TIMES A DAY | U | M45233 | 21446 | 25 | MG | CAPSULE, HARD | TID | ||||
124155212 | 12415521 | 4 | SS | LYRICA | PREGABALIN | 1 | Oral | TWO 50MG TWICE A DAY AND ONE 25MG ONCE A DAY | U | M45233 | 21446 | 125 | MG | CAPSULE, HARD | |||||
124155212 | 12415521 | 5 | SS | LYRICA | PREGABALIN | 1 | 100 MG, 1X/DAY | U | 21446 | 100 | MG | CAPSULE, HARD | QD | ||||||
124155212 | 12415521 | 6 | SS | LYRICA | PREGABALIN | 1 | INCREASED HER DOSE TO FIVE TIMES A DAY | U | 21446 | CAPSULE, HARD | |||||||||
124155212 | 12415521 | 7 | C | ATORVASTATIN | ATORVASTATIN | 1 | 1 DF, DAILY (ONE A DAY) | 0 | 1 | DF |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
124155212 | 12415521 | 1 | Burning sensation |
124155212 | 12415521 | 2 | Cerebrovascular accident |
124155212 | 12415521 | 3 | Burning sensation |
124155212 | 12415521 | 7 | Blood cholesterol abnormal |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
124155212 | 12415521 | Drug ineffective for unapproved indication | |
124155212 | 12415521 | Dyspnoea | |
124155212 | 12415521 | Ear disorder | |
124155212 | 12415521 | Feeling hot | |
124155212 | 12415521 | Hyperhidrosis | |
124155212 | 12415521 | Palpitations | |
124155212 | 12415521 | Peripheral swelling | |
124155212 | 12415521 | Product use issue | |
124155212 | 12415521 | Somnolence |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
124155212 | 12415521 | 1 | 201512 | 201512 | 0 | |
124155212 | 12415521 | 3 | 201512 | 0 | ||
124155212 | 12415521 | 7 | 201511 | 0 |